HUP1100534A2 - Pharmaceutical composition for the treatment of muscle atrophy - Google Patents

Pharmaceutical composition for the treatment of muscle atrophy

Info

Publication number
HUP1100534A2
HUP1100534A2 HU1100534A HUP1100534A HUP1100534A2 HU P1100534 A2 HUP1100534 A2 HU P1100534A2 HU 1100534 A HU1100534 A HU 1100534A HU P1100534 A HUP1100534 A HU P1100534A HU P1100534 A2 HUP1100534 A2 HU P1100534A2
Authority
HU
Hungary
Prior art keywords
treatment
pharmaceutical composition
muscle atrophy
atrophy
muscle
Prior art date
Application number
HU1100534A
Other languages
English (en)
Inventor
Balazs Dr Hazay
Original Assignee
Balazs Dr Hazay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Balazs Dr Hazay filed Critical Balazs Dr Hazay
Priority to HU1100534A priority Critical patent/HUP1100534A2/hu
Priority to EP12805748.6A priority patent/EP2760448A1/en
Priority to PCT/HU2012/000097 priority patent/WO2013045962A1/en
Publication of HUP1100534A2 publication Critical patent/HUP1100534A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU1100534A 2011-09-26 2011-09-26 Pharmaceutical composition for the treatment of muscle atrophy HUP1100534A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HU1100534A HUP1100534A2 (en) 2011-09-26 2011-09-26 Pharmaceutical composition for the treatment of muscle atrophy
EP12805748.6A EP2760448A1 (en) 2011-09-26 2012-09-25 Pharmaceutical composition for the prevention and/or treatment of muscle atrophy
PCT/HU2012/000097 WO2013045962A1 (en) 2011-09-26 2012-09-25 Pharmaceutical composition for the prevention and/or treatment of muscle atrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1100534A HUP1100534A2 (en) 2011-09-26 2011-09-26 Pharmaceutical composition for the treatment of muscle atrophy

Publications (1)

Publication Number Publication Date
HUP1100534A2 true HUP1100534A2 (en) 2013-04-29

Family

ID=89990451

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1100534A HUP1100534A2 (en) 2011-09-26 2011-09-26 Pharmaceutical composition for the treatment of muscle atrophy

Country Status (3)

Country Link
EP (1) EP2760448A1 (hu)
HU (1) HUP1100534A2 (hu)
WO (1) WO2013045962A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207988B (en) 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HU226206B1 (en) 1998-12-14 2008-06-30 Biorex Kutato Fejlesztoe Kft Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
HU226617B1 (en) 1998-12-14 2009-04-28 Cytrx Corp Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
HUP9900475D0 (en) 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
HUP0001583A2 (hu) 2000-04-18 2002-11-28 BIOREX Kutató és Fejlesztő Rt. Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
HUP0303584A3 (en) * 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
CA2728363C (en) * 2008-06-26 2019-02-19 Orphazyme Aps Use of hsp70 as a regulator of enzymatic activity

Also Published As

Publication number Publication date
EP2760448A1 (en) 2014-08-06
WO2013045962A1 (en) 2013-04-04

Similar Documents

Publication Publication Date Title
ZA201403795B (en) Formulations for the treatment of diabetes
EP2554175A4 (en) COMPOSITION FOR THE TREATMENT OF A DESIRED PART
HK1218724A1 (zh) 用於治療瘻的組合物
PL3378862T3 (pl) Dihydropirymidynoizochinolinony i ich kompozycie farmaceutyczne do leczenia stwardnienia rozsianego
HK1193568A1 (en) New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
IL231622B (en) A pharmaceutical preparation for the treatment of stubbornness
EP2558103A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING A MACULAR DERM
EP2769718A4 (en) MEDICINAL COMPOSITION
EP2604264A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRUS DISEASES
PT3081097T (pt) Composição para o tratamento da infertilidade
HUE039724T2 (hu) Injekciós gyógyszerészeti készítmények ízületek kezeléséhez
EP2793875A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF A DIVERTICULOSE
HUP1100290A2 (en) Combination compositions for the treatment of proliferative diseases
HUP1100534A2 (en) Pharmaceutical composition for the treatment of muscle atrophy
EP2730288A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FIBROSIS
EP2712621A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERPROLIFERATIVE DISEASES
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds
HK1196953A1 (zh) 用於治療糖尿病的製劑
ZA201205085B (en) An oral treatment composition
AU2011900519A0 (en) Drug compositions for the treatment of insomnia
PT2812351T (pt) Composição farmacêutica para o tratamento de esclerose múltipla

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees